Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1992 1
2013 1
2015 2
2016 4
2017 2
2018 2
2019 1
2020 4
2021 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Rituximab for High-Risk, Mature B-Cell Non-Hodgkin's Lymphoma in Children.
Minard-Colin V, Aupérin A, Pillon M, Burke GAA, Barkauskas DA, Wheatley K, Delgado RF, Alexander S, Uyttebroeck A, Bollard CM, Zsiros J, Csoka M, Kazanowska B, Chiang AK, Miles RR, Wotherspoon A, Adamson PC, Vassal G, Patte C, Gross TG; European Intergroup for Childhood Non-Hodgkin Lymphoma; Children’s Oncology Group. Minard-Colin V, et al. N Engl J Med. 2020 Jun 4;382(23):2207-2219. doi: 10.1056/NEJMoa1915315. N Engl J Med. 2020. PMID: 32492302 Free PMC article. Clinical Trial.
Model-Based Optimisation of Deferoxamine Chelation Therapy.
Bellanti F, Del Vecchio GC, Putti MC, Cosmi C, Fotzi I, Bakshi SD, Danhof M, Della Pasqua O. Bellanti F, et al. Among authors: cosmi c. Pharm Res. 2016 Feb;33(2):498-509. doi: 10.1007/s11095-015-1805-0. Epub 2015 Nov 10. Pharm Res. 2016. PMID: 26555666 Free PMC article.
The prognostic value of biological markers in paediatric Hodgkin lymphoma.
Farruggia P, Puccio G, Sala A, Todesco A, Buffardi S, Garaventa A, Bottigliero G, Bianchi M, Zecca M, Locatelli F, Pession A, Pillon M, Favre C, D'Amico S, Provenzi M, Trizzino A, Zanazzo GA, Sau A, Santoro N, Murgia G, Casini T, Mascarin M, Burnelli R; AIEOP Italian Association of Pediatric Hematology and Oncology and Hodgkin Lymphoma Working Group. Farruggia P, et al. Eur J Cancer. 2016 Jan;52:33-40. doi: 10.1016/j.ejca.2015.09.003. Epub 2015 Nov 27. Eur J Cancer. 2016. PMID: 26630532
Evaluation of the efficacy and safety of deferiprone compared with deferasirox in paediatric patients with transfusion-dependent haemoglobinopathies (DEEP-2): a multicentre, randomised, open-label, non-inferiority, phase 3 trial.
Maggio A, Kattamis A, Felisi M, Reggiardo G, El-Beshlawy A, Bejaoui M, Sherief L, Christou S, Cosmi C, Della Pasqua O, Del Vecchio GC, Filosa A, Cuccia L, Hassab H, Kreka M, Origa R, Putti MC, Spino M, Telfer P, Tempesta B, Vitrano A, Tsang YC, Zaka A, Tricta F, Bonifazi D, Ceci A. Maggio A, et al. Among authors: cosmi c. Lancet Haematol. 2020 Jun;7(6):e469-e478. doi: 10.1016/S2352-3026(20)30100-9. Lancet Haematol. 2020. PMID: 32470438 Clinical Trial.
Early response does not predict outcome in children and adolescents with chronic myeloid leukaemia treated with high-dose imatinib.
Giona F, Saglio G, Santopietro M, Menna G, Putti MC, Micalizzi C, Iaria G, Santoro N, Ladogana S, Mura R, Burnelli R, Consarino C, Cosmi C, Moleti ML, Leszl A, Tucci F, Nanni M, Diverio D, Biondi A, Locatelli F, Foà R. Giona F, et al. Among authors: cosmi c. Br J Haematol. 2018 Mar;180(6):895-898. doi: 10.1111/bjh.14458. Epub 2016 Dec 16. Br J Haematol. 2018. PMID: 27984633 Free article. Clinical Trial. No abstract available.
Population pharmacokinetics and dosing recommendations for the use of deferiprone in children younger than 6 years.
Bellanti F, Del Vecchio GC, Putti MC, Maggio A, Filosa A, Cosmi C, Mangiarini L, Spino M, Connelly J, Ceci A, Della Pasqua O; Consortium DEferiprone Evaluation in Paediatrics (DEEP). Bellanti F, et al. Among authors: cosmi c. Br J Clin Pharmacol. 2017 Mar;83(3):593-602. doi: 10.1111/bcp.13134. Epub 2016 Nov 6. Br J Clin Pharmacol. 2017. PMID: 27641003 Free PMC article. Clinical Trial.
Reply to Comment on Pietrapertosa et al. How to Prioritize Energy Efficiency Intervention in Municipal Public Buildings to Decrease CO2 Emissions? A Case Study from Italy. Int. J. Environ. Res. Public Health 2020, 17, 4434.
Pietrapertosa F, Tancredi M, Giordano M, Cosmi C, Salvia M. Pietrapertosa F, et al. Among authors: cosmi c. Int J Environ Res Public Health. 2021 Apr 4;18(7):3760. doi: 10.3390/ijerph18073760. Int J Environ Res Public Health. 2021. PMID: 33916519 Free PMC article.
14 results